• 1
    Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003; 98: 4129.
  • 2
    O'Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128: 54151.
  • 3
    Cooke RA, Van der Veer A. Human sensitization. J immunol 1916; 1: 201305.
  • 4
    Loveless MH. Milk allergy: a survey of its incidence: experience with masked ingestion test. J Allergy 1950; 21: 489.
  • 5
    Graham DT, Wolf S, Wolf HG. Changes in tissue sensitivity associated with varying life situations and emotions: their relevance to allergy. J Allergy 1950; 21: 478.
  • 6
    Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 112.
  • 7
    Bock SA. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics 1987; 79: 6838.
  • 8
    Sampson HA. Update on food allergy. J Allergy Clin Immunol 2004; 113: 80519.
  • 9
    Bruijnzeel-Koomen C, Ortolani C, Aas K et al. Adverse reactions to food. Allergy 1995; 50: 62335.
  • 10
    Shanahan F. Food allergy: fact, fiction, and fatality. Gastroenterology 1993; 104: 122931.
  • 11
    Young E, Stoneham MD, Petruckevitch A, Barton J, Rona R. A population study of food intolerance. Lancet 1994; 343: 112730.
  • 12
    Bischoff SC, Herrmann A, Manns MP. Prevalence of adverse reactions to food in patients with gastrointestinal disease. Allergy 1996; 51: 8118.
  • 13
    Nanda R, James R, Smith H, Dudley CR, Jewell DP. Food intolerance and the irritable bowel syndrome. Gut 1989; 30: 1099104.
  • 14
    Dainese R, Ce Galliani EA, Lazzari F, Di Leo V, Naccarato R. Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol 1999; 94: 18927.
    Direct Link:
  • 15
    Bischoff S, Crowe SE. Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology 2005; 128: 1089113.
  • 16
    Ciprandi G, Canonica GW. Incidence of digestive diseases in patients with adverse reactions to foods. Ann Allergy 1988; 61: 3346.
  • 17
    Haderstorfer B, Psycholgin D, Whitehead WE, Schuster MM. Intestinal gas production from bacterial fermentation of undigested carbohydrate in irritable bowel syndrome. Am J Gastroenterol 1989; 84: 3758.
  • 18
    Tolliver BA, Jackson MS, Jackson KL, Barnett ED, Chastang JF, DiPalma JA. Does lactose maldigestion really play a role in the irritable bowel syndrome? J Clin Gastroenterol 1996; 23: 157.
  • 19
    Johannson SG, Dannaeus A, Lilja G. The relevance of antifood antibodies for the diagnosis of food allergy. Ann Allergy 1984; 53: 66570.
  • 20
    Untersmayr E, Scholl I, Swoboda I et al. Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice. J Allergy Clin Immunol 2003; 112: 61623.
  • 21
    Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005; 307: 19205.
  • 22
    Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev immunol 2003; 3: 71020.
  • 23
    Podolsky D. Mucosal immunity and inflammation. Innate mechanisms of mucosal defense and repair: the best offence is a good defense. Am J Physiol 1999; 277: G495G499.
  • 24
    Jackson PG, Lessof MH, Baker RW, Ferrett J, MacDonald DM. Intestinal permeability in patients with eczema and food allergy. Lancet 1981; 13: 12856.
  • 25
    Andre C. Food allergy. Objective diagnosis and test of therapeutic efficacy by measuring intestinal permeability. Presse Med 1986; 25: 1058.
  • 26
    Heyman M, Grasset E, Ducroc R, Desjeux JF. Antigen absorption by the jejunal epithelium of children with cow's milk allergy. Pediatr Res 1988; 24: 197202.
  • 27
    Tatsuno K. Intestinal permeability in children with food allergy. Arerugi 1989; 38: 13118.
  • 28
    Laudat A, Arnaud P, Napoly A, Brion F. The intestinal permeability test applied to the diagnosis of food allergy in paediatrics. West Ind Med J 1994; 43: 878.
  • 29
    Kohout P, Ettlerova K, Bratova M, Zadak Z. Intestinal permeability in patients with food allergy. Vnitr Lek 1998; 44: 2635.
  • 30
    Husby S, Forged N, Host A, Svehag SE. Passage of dietary antigens into the blood of children with celiac disease: quantification and size distribution of absorbed antigens. Gut 1987; 28: 106272.
  • 31
    Reinhardt MC. Macromolecular absorption of food antigens in health and disease. Ann Allergy 1984; 53: 597601.
  • 32
    Chase MW. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol 1946; 61: 257259.
  • 33
    Chehade M, Mayer L. Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol 2005; 115: 312.
  • 34
    Zeiger R. Breast-feeding and dietary avoidance. In: De WeckA, SampsonH, eds. Intestinal Immunology and Food Allergy, New York: Raven Press, 1995: 20322.
  • 35
    Jarvinen KM, Suomalainen H. Development of cow's milk allergy in breast-fed infants. Clin Exp Allergy 2001; 31: 97887.
  • 36
    Kaplan MS, Solli NJ. Immunoglobulin E to cow's-milk protein in breast-fed atopic children. J Allergy Clin Immunol 1979; 64: 1226.
  • 37
    Taylor B, Wadsworth J, Golding J, Butler N. Breast feeding, eczema, asthma, and hayfever. J Epidemiol Community Health 1983; 37: 959.
  • 38
    Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159: 173945.
  • 39
    Bischoff S, Crowe SE. Food allergy and the gastrointestinal tract. Curr Opin Gastroenterol 2004; 20: 15661.
  • 40
    Steinke JW, Borish L, Rosenwasser LJ. Genetics of hypersensitivity. J Allergy Clin Immunol 2003; 111: S495S501.
  • 41
    Howard TD, Meyers DA, Bleecker ER. Mapping susceptibility genes for allergic diseases. Chest 2003; 123: 363S368S.
  • 42
    Breiteneder H, Ebner C. Molecular and biochemical classification of plant-derived food allergens. J Allergy Clin Immunol 2001; 31: 10315.
  • 43
    Sampson HA. Food allergy. Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol 1999; 103: 71728.
  • 44
    Romagnuolo J, Schiller D, Bailey RJ. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol 2002; 97: 111326.
    Direct Link:
  • 45
    Di Stefano M, Miceli E, Malservisi S, Missanelli A, Strocchi A, Corazza GR. Mixing of the intestinal content and variations of fermentation capacity do not affect the results of hydrogen breath test. Am J Gastroenterol 2003; 98: 15847.
  • 46
    Bruijnzeel-Koomen C, Ortolani C, Aas K et al. Adverse reactions to food. European Academy of Allergology and Clinical Immunology Subcommittee. Allergy 1995; 50: 62335.
  • 47
    Sampson HA, Sicherer SH, Birnbaum AH. AGA technical review on the evaluation of food allergy in gastrointestinal disorders. American Gastroenterological Association. Gastroenterology 2001; 120: 102640.
  • 48
    Sicherer SH. Food allergy. Lancet 2002; 360: 70110.
  • 49
    Bischoff SC, Mayer JH, Manns MP. Allergy and gut. Int Arch Allergy Immunol 2000; 121: 27083.
  • 50
    Bischoff SC, Mayer J, Wedemeyer J et al. Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergy. Gut 1997; 40: 74553.
  • 51
    Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999; 45: II37II42.
  • 52
    Read NW. Food and hypersensitivity in functional dyspepsia. Gut 2002; 51 (Suppl. 1): i503.
  • 53
    Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther 2004; 20 (Suppl. 2): 19.
  • 54
    Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003; 124: 166271.
  • 55
    Chaudhary NA, Truelove SC. The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med 1962; 31: 30722.
  • 56
    McKendrick MW, Read NW. Irritable bowel syndrome–post salmonella infection. J Infect 1994; 29: 13.
  • 57
    Gwee KA, Graham JC, McKendrick MW et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 1503.
  • 58
    Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997; 314: 77982.
  • 59
    Gwee KA, Leong YL, Graham C et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999; 44: 4006.
  • 60
    Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ 1999; 318: 5656.
  • 61
    Parry SD, Stansfield R, Jelley D et al. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol 2003; 98: 19705.
  • 62
    Ji S, Park H, Lee D, Song YK, Choi JP, Lee SI. Post-infectious irritable bowel syndrome in patients with Shigella infection. J Gastroenterol Hepatol 2005; 20: 3816.
  • 63
    Ilnyckyj A, Balachandra B, Elliott L, Choudhri S, Duerksen DR. Post-traveler's diarrhoea irritable bowel syndrome: a prospective study. Am J Gastroenterol 2003; 98: 5969.
    Direct Link:
  • 64
    Hiatt RB, Katz L. Mast cells in inflammatory conditions of the gastrointestinal tract. Am J Gastroenterol 1962; 37: 5415.
  • 65
    Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993; 38: 15905.
  • 66
    O'Sullivan M, Clayton N, Breslin NP et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000; 12: 44957.
  • 67
    Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693702.
  • 68
    O'Sullivan MA, Clayton N, Wong T, Bountra C, Buckley MM, O'Morain CA. Increased inos and nitrotyrosine expression in irritable bowel syndrome (IBS). Gastroenterology 2000; 118: A702.
  • 69
    Tornblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002; 123: 19729.
  • 70
    Spiller RC, Jenkins D, Thornley JP et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 80411.
  • 71
    Chadwick VS, Chen W, Shu D et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122: 177883.
  • 72
    Liu S, Hu HZ, Gao N et al. Neuroimmune interactions in guinea pig stomach and small intestine. Am J Physiol Gastrointest Liver Physiol 2003; 284: G15464.
  • 73
    Schemann M, Michel K, Ceregrzyn M, Zeller F, Seidl S, Bischoff SC. Human mast cell mediator cocktail excites neurons in human and guinea-pig enteric nervous system. Neurogastroenterol Motil 2005; 17: 2819.
  • 74
    Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005; 25: 19205.
  • 75
    Jones VA, McLaughlan P, Shorthouse M, Workman E, Hunter JO. Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet 1982; 2: 11157.
  • 76
    Bentley SJ, Pearson DJ, Rix KJ. Food hypersensitivity in irritable bowel syndrome. Lancet 1983; 2: 2957.
  • 77
    Farah DA, Calder I, Benson L, MacKenzie JF. Specific food intolerance: its place as a cause of gastrointestinal symptoms. Gut 1985; 26: 1648.
  • 78
    Petitpierre M, Gumowski P, Girard JP. Irritable bowel syndrome and hypersensitivity to food. Ann Allergy 1985; 54: 53840.
  • 79
    McKee AM, Prior A, Whorwell PJ. Exclusion diets in irritable bowel syndrome: are they worthwhile? J Clin Gastroenterol 1987; 9: 5268.
  • 80
    Zwetchkenbaum J, Burakoff R. The irritable bowel syndrome and food hypersensitivity. Ann Allergy 1988; 61: 479.
  • 81
    Stefanini GF, Prati E, Albini MC et al. Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol 1992; 87: 557.
  • 82
    Stefanini GF, Saggioro A, Alvisi V et al. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol 1995; 30: 53541.
  • 83
    Bolin TD. Use of oral sodium cromoglycate in persistent diarrhoea. Gut 1980; 21: 84850.
  • 84
    Lunardi C, Bambara LM, Biasi D et al. Double-blind cross-over trial of oral sodium cromoglycate in patients with irritable bowel syndrome due to food intolerance. Clin Exp Allergy 1991; 21: 56972.
  • 85
    Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004; 53: 145964.
  • 86
    Stefanini GF, Bazzocchi G, Prati E, Lanfranchi GA, Gasbarrini G. Efficacy of oral disodium cromoglycate in patients with irritable bowel syndrome and positive skin prick tests to foods. Lancet 1986; 1: 2078.
  • 87
    White AM, Stevens WH, Upton AR, O'Byrne PM, Collins SM. Airway responsiveness to inhaled methacholine in patients with irritable bowel syndrome. Gastroenterology 1991; 100: 6874.
  • 88
    Roussos A, Koursarakos P, Patsopoulos D, Gerogianni I, Philippou N. Increased prevalence of irritable bowel syndrome in patients with bronchial asthma. Respir Med 2003; 97: 759.
  • 89
    Crowe SE, Perdue MH. Gastrointestinal food hypersensitivity: basic mechanisms of pathophysiology. Gastroenterology 1992; 103: 107595.
  • 90
    Barau E, Dupont C. Modifications of intestinal permeability during food provocation procedures in pediatric irritable bowel syndrome. J Pediatr Gastroenterol Nutr 1990; 11: 727.
  • 91
    Andre F, Andre C, Colin L, Cavagna S. IgE in stools as indicator of food sensitization. Allergy 1995; 50: 32833.
  • 92
    Bischoff SC, Mayer J, Meier PN, Zeck-Kapp G, Manns MP. Clinical significance of the colonoscopic allergen provocation test. Int Arch Allergy Immunol 1997; 113: 34851.
  • 93
    Merrett J, Burr ML, Merrett TG. A community survey of IgG4 antibody levels. Clin Allergy 1983; 13: 397407.
  • 94
    Barnes RM, Barton PG, Doig JE, Finn R, Harvey MM, Johnson PM. Distribution of serum antibodies to wheat gliadin and bovine milk in atopic and non-atopic healthy adults. J Clin Lab Immunol 1983; 12: 1758.
  • 95
    Husby S, Oxelius VA, Teisner B, Jensenius JC, Svehag SE. Humoral immunity to dietary antigens in healthy adults. Occurrence, isotype and IgG subclass distribution of serum antibodies to protein antigens. Int Arch Allergy Appl Immunol 1985; 77: 41622.
  • 96
    Johansson SG, Dannaeus A, Lilja G. The relevance of anti-food antibodies for the diagnosis of food allergy. Ann Allergy 1984; 53: 66572.
  • 97
    Finn R, Smith MA, Youngs GR, Chew D, Johnson PM, Barnes RM. Immunological hypersensitivity to environmental antigens in the irritable bowel syndrome. Br J Clin Pract 1987; 41: 10413.
  • 98
    El Rafei A, Peters SM, Harris N, Bellanti JA. Diagnostic value of IgG4 measurements in patients with food allergy. Ann Allergy 1989; 62: 949.
  • 99
    Miyamoto T, Koya N, Suzuki S et al. Clinical significance of specific IgG4 antibody in serum. Arerugi 1991; 40: 21523.
  • 100
    Zar S, Benson MJ, Kumar D. Serum IgG4 antibodies to common food antigens are elevated in irritable bowel syndrome. Gut 2002; 50 (Suppl. 11): A25.
  • 101
    Nakagawa T, De Weck AL. Membrane receptors for the IgG4 subclass on human basophils and mast cells. Clin Rev Allergy 1983; 1: 197206.
  • 102
    Nakagawa T, Okano Y, Iwasaki E et al. Clinical significance of IgG4 antibody determination in children against egg white, milk, soybean and Dermatophagoides farinae. Arerugi 1992; 41: 1694704.
  • 103
    Locke GR III, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol 2000; 95: 15765.
    Direct Link:
  • 104
    Niec AM, Frankum B, Talley NJ. Are adverse food reactions linked to irritable bowel syndrome? Am J Gastroenterol 1998; 93: 218490.
    Direct Link:
  • 105
    Shin HY, Kim JS, An NH, Park RK, Kim HM. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions. Life Sci 2004; 74: 287787.
  • 106
    Okayama Y, Benyon RC, Rees PH, Lowman MA, Hillier K, Church MK. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin Exp Allergy 1992; 22: 4019.
  • 107
    Brostoff J, Carini C, Wraith DG, Johns P. Production of IgE complexes by allergen challenge in atopic patients and the effect of sodium cromoglycate. Lancet 1979; 1: 126870.
  • 108
    Ortolani C, Pastorello E, Zanussi C. Prophylaxis of adverse reactions to foods. A double-blind study of oral sodium cromoglycate for the prophylaxis of adverse reactions to foods and additives. Ann Allergy 1983; 50: 1059.
  • 109
    Businco L, Benincori N, Nini G, Businco E, Cantani A, De Angelis M. Double-blind crossover trial with oral sodium cromoglycate in children with atopic dermatitis due to food allergy. Ann Allergy 1986; 57: 4338.
  • 110
    Zar S, Kumar D, Kumar D. Role of food hypersensitivity in irritable bowel syndrome. Minerva Med 2002; 93: 40312.
  • 111
    Woolhiser MR, Brockow K, Metcalfe DD. Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a. Clin Immunol 2004; 110: 17280.